Clinical Trials Browser

Phase 2 × Biliary Tract Neoplasms × Immune Checkpoint Inhibitors × Clear all

NCT07282262 2025-12-15

An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.

Phase 2 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT05509478 2022-09-10

LEADER-001

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms